Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy

被引:36
|
作者
von Gruenigen, Vivian E. [1 ]
Frasure, Heidi E. [2 ]
Kavanagh, Mary Beth [3 ]
Lerner, Edith [3 ]
Waggoner, Steven E. [2 ]
Courneya, Kerry S. [4 ]
机构
[1] Summa Hlth Syst Akron City Hosp, Akron, OH USA
[2] Univ Hosp, Case Med Ctr, Cleveland, OH USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
[4] Univ Alberta, Edmonton, AB, Canada
关键词
Ovarian cancer; Lifestyle; Nutrition; Physical activity; Quality of life; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; FUNCTIONAL ASSESSMENT; RANDOMIZED-TRIAL; FATIGUE; SURVIVAL; EXERCISE; ASSOCIATIONS; VALIDITY; EVENTS;
D O I
10.1016/j.ygyno.2011.04.043
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. This study aimed to assess the feasibility of a lifestyle intervention for promoting physical activity (PA) and diet quality during adjuvant chemotherapy for ovarian cancer. Methods. Patients were enrolled post-operatively and received PA and nutrition counseling, at every chemotherapy visit for six cycles. Quality of life (QoL) was measured with the Functional Assessment of Cancer Therapy (FACT-G), PA with the Leisure Score Index (LSI), dietary intake with 3-day food records, and symptom severity/distress by the Memorial Symptom Assessment Scale (MSAS). Pedometer step count was collected during chemotherapy cycles. Results. Recruitment was 73% with 27 patients enrolled. Mean [95% confidence interval] change in minutes of PA from cycle #3 to following cycle #6 was 61 min [-3, 120] p = 0.063, and from baseline to after cycle #6 was 73 min [-10, 15]; p = 0.082. Mean change in total fruit and vegetable consumption between baseline and during chemotherapy was 0.56 [-0.09, 0.64]; p = 0.090. FACT-G increased from 75.4 at baseline to 77.6 during chemotherapy and 83.9 following chemotherapy (p = 0.001 for change from baseline to post-chemotherapy). Mean total MSAS score was 20.6 at baseline, 26.6 at cycle #3 and decreased to 17.0 following chemotherapy (p = 0.01 comparison of cycle #3 and following chemotherapy). Increased moderate to strenuous PA was correlated with higher physical well-being during chemotherapy (r = 0.48, p = 0.037). Conclusions. Lifestyle counseling during adjuvant chemotherapy for ovarian cancer is feasible and may improve PA and diet quality. Randomized controlled trials examining the effects of lifestyle counseling on quality of life and treatment outcomes in ovarian cancer patients are warranted. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:328 / 333
页数:6
相关论文
共 50 条
  • [21] Comparison of outcomes of primary mucinous ovarian cancer patients receiving either an adjuvant gynecologic or gastrointestinal chemotherapy regimen
    Schlappe, B.
    Zhou, Q.
    O'Cearbhaill, R.
    Iasonos, A.
    Soslow, R. A.
    Abu-Rustum, N. R.
    Mueller, J. J.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 236 - 236
  • [22] The Significance of the Length of an adjuvant Chemotherapy for the Prognosis of Patients with Ovarian Cancer
    Seebacher, V.
    Grimm, C.
    Polterauer, S.
    Hefler, L.
    Reinthaller, A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2012, 72 (04)
  • [23] Serum erythropoietin levels in ovarian cancer patients receiving chemotherapy
    Pedain, C
    Herrero, J
    Künzel, W
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 98 (02) : 224 - 230
  • [24] VENOUS THROMBOEMBOLISM IN PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY FOR OVARIAN CANCER
    Black, K.
    Ghosh, S.
    Singh, N.
    Chu, P.
    Pin, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A133 - A133
  • [25] Feasibility of neoadjuvant and adjuvant intraperitoneal chemotherapy in patients with advanced epithelial ovarian cancer A single-center experience
    Liu, Yu
    Cao, Lili
    Chen, Wei
    Wang, Jingjing
    Wang, Wenting
    Liang, Zhiqing
    MEDICINE, 2020, 99 (36) : E22100
  • [26] Fatigue in patients with breast cancer receiving adjuvant chemotherapy: A review of the literature
    de Jong, N
    Courtens, AM
    Abu-Saad, HH
    Schouten, HC
    CANCER NURSING, 2002, 25 (04) : 283 - 297
  • [27] Fatigue in early breast cancer patients receiving adjuvant postoperative chemotherapy
    Heras, P.
    Hatzopoulos, A.
    Kritikos, K.
    Kapouralos, A.
    Androutsos, N.
    BREAST, 2009, 18 : S70 - S70
  • [28] BRAIN METASTASES IN BREAST-CANCER PATIENTS RECEIVING ADJUVANT CHEMOTHERAPY
    PATERSON, AHG
    AGARWAL, M
    LEES, A
    HANSON, J
    SZAFRAN, O
    CANCER, 1982, 49 (04) : 651 - 654
  • [29] Level of fatigue in colorectal cancer patients (ccp) receiving adjuvant chemotherapy
    Heras, P.
    Hatzopoulos, A.
    Kritikos, K.
    Karagiannis, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] The development of anticipatory nausea in patients receiving adjuvant chemotherapy for breast cancer
    Montgomery, GH
    Bovbjerg, DH
    PHYSIOLOGY & BEHAVIOR, 1997, 61 (05) : 737 - 741